Cytokines in the Progression of Pancreaticβ-Cell Dysfunction
Author(s) -
Chunjiong Wang,
Youfei Guan,
Jichun Yang
Publication year - 2010
Publication title -
international journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.875
H-Index - 60
eISSN - 1687-8345
pISSN - 1687-8337
DOI - 10.1155/2010/515136
Subject(s) - medicine , adiponectin , islet , resistin , cytokine , leptin , endocrinology , pancreatic islets , beta cell , cancer research , diabetes mellitus , immunology , insulin resistance , obesity
The dysfunction of pancreatic β -cell and the reduction in β -cell mass are the decisive events in the progression of type 2 diabetes. There is increasing evidence that cytokines play important roles in the procedure of β -cell failure. Cytokines, such as IL-1 β , IFN- γ , TNF- α , leptin, resistin, adiponectin, and visfatin, have been shown to diversely regulate pancreatic β -cell function. Recently, islet-derived cytokine PANcreatic DERived factor (PANDER or FAM3B) has also been demonstrated to be a regulator of islet β -cell function. The change in cytokine profile in islet and plasma is associated with pancreatic β -cell dysfunction and apoptosis. In this paper, we summarize and discuss the recent studies on the effects of certain important cytokines on pancreatic β -cell function. The imbalance in deleterious and protective cytokines plays pivotal roles in the development and progression of pancreatic β -cell dysfunction under insulin-resistant conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom